You will meet a "who's who" of the biopharma industry. This year's Summit includes executives, investors and innovators from:

  • 3SBio
  • AbbVie
  • Affini-T Therapeutics
  • Agent Capital
  • Akeso
  • Ally Bridge Group
  • Alphamab Oncology
  • Amgen
  • Angelini Ventures
  • Antengene
  • Argo Biopharma
  • Ascentage Pharma
  • Axil Capital
  • Bambusa Therapeutics
  • Bayer
  • Bayland Capital
  • BioMarin Pharmaceutical
  • Biotheus
  • Boehringer Ingelheim
  • Caidya
  • Candid Therapeutics
  • Cathay
  • Charles River Labs
  • Cipla
  • D3 Bio
  • Daiichi Sankyo
  • DotBio
  • Duality Biologics
  • Eli Lilly and Company
  • EnnovaBio
  • EpiMab Biotherapeutics
  • EsoBiotec
  • Frazier Life Sciences
  • Fudan University
  • GEXVal
  • Gilde Healthcare Partners
  • Goldman Sachs
  • GSK
  • Guangzhou-Israel Biotechnology Fund
  • GV
  • HanchorBio
  • Harbour BioMed
  • H.C. Wainwright
  • Hillgene
  • Hony Capital
  • Hua Medicines
  • Hummingbird Bioscience
  • Innovent Biologics
  • Jiangsu Hengrui Medicine
  • Johns Hopkins
  • Lake Bleu Capital
  • LaNova Medicines
  • Leads Biolabs
  • Lilly Asia Ventures
  • McKinsey & Company
  • Med-Fine Capital
  • Meditrust Health
  • Merck KGaA
  • Mizuho Securities
  • Neushen Therapeutics
  • Novo Holdings
  • Novo Nordisk
  • OrbiMed
  • Orum Therapeutics
  • Otsuka Pharmaceutical
  • Pacific Bridge
  • Panacea Venture
  • Peking University
  • Pivotal Life Sciences
  • Quan Capital
  • RDPAC
  • Roche
  • Sanofi
  • Servier Group
  • Sciwind
  • Shanghai Clinical Research and Trial Center
  • Simcere
  • Stifel
  • Swedish Orphan Biovitrum
  • Syneron Bio
  • Takeda
  • Transcenta
  • Westlake University
  • ZhongMei Capital
  • And many more...